Correlating antibody effector function to product efficacy

Helping biopharma analyze mechanisms of humoral immunity to develop potent antibody therapeutics and protective vaccines.

Seromyx

Systems Serology combines high-throughput assays and computational analysis for unprecedented insight into immune function.

The SeromYx Advantage

HIGH THROUGHPUT

Robustly and repeatably process thousands of samples

ASSAY BREADTH

Unique breadth of assay offering, characterizing both function and biophysical attributes

ADVANCED COMPUTATIONAL BIOLOGY

Machine learning algorithms to interpret high dimensional datasets and avoid overfitting

EXPERTISE

Extensive experience of senior staff to customize projects to client needs and interpret results

Application Areas

THERAPEUTIC ANTIBODIES

Determining antibody features that predict successful treatment

VACCINES

Identifying antibody effector functions that are correlated with vaccine-induced immunity

SARS-COV2

From immune correlates
and mAb function to vaccine
clinical development

Events

World Vaccine Congress US 2025

April 22-24, 2025│Washington, DC

Visit Booth 646 or attend the presentation by our VP of Research, Lenny Moise, on April 23rd from 3:40–4:30 PM to learn more about broadly profiling Fc effector functions for vaccine and immunotherapeutic development.

Fc-mediated Function Summit

July 29-31, 2025│Boston, MA

Visit our stand or attend the presentation by our Director of Research, Shashi Jatiani, on July 30th from 2:30-3 PM to learn more about unlocking the power of Fc: Guiding antibody development with deep effector function insights.

Let’s Talk – Contact us today to discuss your project.